COMPANY NEWS
©
t
h
g
i
r
y
op for Roche Canadatribution
A NewC
Home
l Dis
a
i
c
r
e
m
load,
m
o
C
r
o
rs can down
e
s
e
u
l
d
a
e
s
S
ri
o
r
th
Grand
Celebration
Open
ot foOpening
N
onal usethe Doors
rohibited. Auto Officially
orised use p
copy for pers
gle
nauth
rint a sin
ofURoche
Canada’s
Corporate
Headquarters
and pNew
w
ie
v
,
y
la
p
is
d
at 7070 Mississauga Road
“This is a very exciting day for Roche Canada
as we move into a building that is truly
representative of our company and our
future — bright, energetic, and collaborative,”
explained Ronnie Miller, President
and CEO of Roche Canada. “I am thrilled to
welcome so many people to our corporate
house-warming.”
Dr. Franz Humer, Chairman of the Board of Directors of Roche
Holding Limited (left) and Ronnie Miller, President and CEO of
Roche Canada (right) marking the grand opening of Roche’s new
corporate headquarters with a ribbon cutting ceremony
H
offmann-La Roche Limited (Roche Canada)
recently celebrated the grand opening of its
new pharmaceutical headquarters at 7070 Mississauga Road, Mississauga, Ontario. The celebration
was hosted by Ronnie Miller, President and CEO of
Roche Canada, who was joined by special guest
Dr. Franz Humer, Chairman of the Board of Directors
of Roche Holding Limited, colleagues from Roche
Canada, as well as members of all levels of government,
including members of the Government of Switzerland.
Roche Canada’s pharmaceutical division, previously
located at 2455 Meadowpine Boulevard in Mississauga,
employs 621 people in Canada, 500 (full-time, permanent) of whom are based at the head office in
Mississauga.
32
Canadian Pharmaceutical Marketing l November/December 2013
Ronnie Miller (far right) welcoming dignitaries
and past and present employees in the main atrium
of Roche Canada’s new corporate headquarters
Company News
Roche In Canada
Roche Canada’s pharmaceutical and diagnostics divisions have generated more than $1 billion in total economic activity and have supported 4,786 jobs, both
directly and indirectly, across Canada over the past two
years.
Hoffmann-La Roche Limited was founded in Montréal,
Québec in 1931.
Roche Diagnostics Canada remains in Québec with its
head office based in Laval. In 2001, as a result of significant growth, Roche Diagnostics Canada doubled its
warehouse facility and, in 2007, invested $20 million to
renovate and expand its office building.
The pharmaceutical headquarters remained in Québec
until 1983, when it moved to the Greater Toronto Area.
First located in Etobicoke, Roche Pharmaceuticals
moved to Meadowpine Boulevard in Mississauga in
1990.
In 2011, Roche Pharmaceuticals announced a significant expansion with the introduction of a Global Pharmaceutical Development site, which plays a leadership
role in worldwide clinical trials. The project involved
an investment by Roche of more than $190 million
in Ontario and has resulted in growth from 76 to 236
people in Pharmaceutical Development since the
Dr. Franz Humer (left) and Ronnie Miller (right)
celebrating at the grand opening of Roche Canada’s
new corporate headquarters
announcement. The expansion project is supported by
a $7.79 million investment from the Government of Ontario, and it reflects the shared commitment of Roche
and the Government of Ontario to build long-term
prosperity and international leadership in life sciences
and biopharmaceuticals in the province.
On October 2, Roche Canada’s Pharmaceutical division opened the doors to a brand new facility at 7070
Mississauga Road, Mississauga, Ontario and relocated
its employees to a facility that is updated, vibrant, fosters
collaboration and teamwork, and is reflective of Roche’s
truly innovative culture.
CPM
Canadian Pharmaceutical Marketing l November/December 2013
33